Erythropoietin drug delivery system

Details Erythropoietin drug delivery system Erythropoietin drug delivery system

A - Human Necessities

61

K

A61K 38/22 (2006.01) A61K 9/16 (2006.01) A61K 47/34 (2006.01) A61K 47/42 (2006.01) A61K 47/02 (2006.01)

Patent

CA 2136434

Biodegradable polymer microspheres, preferably formed of zein, are used for in vivo release of erythropoietin (EPO). Ex-amples demonstrate administration of the EPO in zein and polylactides and polymer microspheres to dogs and monkeys, with appropriate increases in blood levels and an increase in reticulocyte counts.

Affiliated with

Also associated with

Rating

Erythropoietin drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythropoietin drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin drug delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1532761